Melina M Georgousakis - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Expert Review of Vaccines|June 3, 2009

Moving forward: a mucosal vaccine against group A streptococcusMelina M Georgousakis, David J McMillan, Michael R Batzloff, et al.

Expert Review of Vaccines|November 13, 2009

Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines?Pierre R Smeesters, David J McMillan, Kadaba S Sriprakash, et al.

Vaccine|September 5, 2009

Structural optimisation of a conformational epitope improves antigenicity when expressed as a recombinant fusion proteinMelina M Georgousakis, Andreas Hofmann, Michael R Batzloff, et al.

Vaccine|January 24, 2012

Evaluation of novel Streptococcus pyogenes vaccine candidates incorporating multiple conserved sequences from the C-repeat region of the M-proteinMichelle J Bauer, Melina M Georgousakis, Therese Vu, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Expert Review of Vaccines|June 3, 2009

Moving forward: a mucosal vaccine against group A streptococcusMelina M Georgousakis, David J McMillan, Michael R Batzloff, et al.

Expert Review of Vaccines|November 13, 2009

Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines?Pierre R Smeesters, David J McMillan, Kadaba S Sriprakash, et al.

Vaccine|September 5, 2009

Structural optimisation of a conformational epitope improves antigenicity when expressed as a recombinant fusion proteinMelina M Georgousakis, Andreas Hofmann, Michael R Batzloff, et al.

Vaccine|January 24, 2012

Evaluation of novel Streptococcus pyogenes vaccine candidates incorporating multiple conserved sequences from the C-repeat region of the M-proteinMichelle J Bauer, Melina M Georgousakis, Therese Vu, et al.

Pageof 1